Choice A rationale

Sucralfate is not commonly used to treat irritable bowel syndrome. Irritable bowel syndrome is typically managed with dietary modifications, stress management, and medications to control specific symptoms such as constipation or diarrhea.

Choice B rationale

Sucralfate is not commonly used to treat Crohn’s disease. Crohn’s disease is an inflammatory bowel disease that is typically managed with anti-inflammatory medications, immune system suppressors, and antibiotics.

Choice C rationale

Sucralfate is commonly used to treat gastric ulcers. It works by forming a protective barrier over the ulcer, which helps protect the ulcer from further damage by stomach acid and allows it to heal.

Choice D rationale

While sucralfate can be used to treat symptoms of gastroesophageal reflux disease (GERD), it is not the first-line treatment. Other medications, such as proton pump inhibitors and H2 blockers, are typically used first.

Choice A rationale
Before starting an enteral feeding using a newly inserted nasogastric feeding tube, it is crucial to review abdominal x-ray results to confirm the correct placement of the tube.
Choice B rationale

While reviewing chest x-ray results can provide useful information about the patient’s overall health, it is not specifically required before starting an enteral feeding.
Choice C rationale
Flushing the feeding tube is an important step in maintaining tube patency, but it does not need to be done specifically before starting an enteral feeding.
Choice D rationale
Auscultating bowel sounds can provide information about gastrointestinal function, but it is not specifically required before starting an enteral feeding.